Propiverine tablet

DRUG2 trials

Sponsors

Astellas Pharma Inc, Furkan Adem Canbaz

Conditions

Enuresis, NocturnalOveractive Bladder (OAB)

Phase 4

Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.

CompletedNCT02294396

Astellas Pharma IncOveractive Bladder (OAB)

Start: 2014-10-28End: 2016-09-07Updated: 2024-10-31

Unknown Phase

Uroflowmetry and Nocturnal Enuresis

Active, not recruitingNCT07028645

Furkan Adem CanbazEnuresis, Nocturnal

Start: 2022-08-20End: 2025-12-30Target: 100Updated: 2025-06-24